Is STE or UTHR cheaper?

On trailing earnings, UTHR is cheaper: STE trades at a 26.56 P/E and UTHR at 20.09.

Which has grown faster, STE or UTHR?

Over the past five years, UTHR grew revenue faster — STE at a 13.82% CAGR versus UTHR at 16.05%.

Does STE or UTHR pay a bigger dividend?

STE pays a dividend (1.20% yield) while UTHR does not currently pay one.

Is STE or UTHR more profitable?

UTHR runs the higher net margin — STE at 13.18% versus UTHR at 40.61%.

Which has been the better investment, STE or UTHR?

Over the past 10-year, UTHR delivered the higher annualized total return — STE at 13.60% versus UTHR at 18.19%. Past performance doesn't predict future results.

STERIS plc (STE) vs United Therapeutics Corporation (UTHR)

UTHR leads on 10 of 16 compared metrics.

A side-by-side comparison of STERIS plc and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

United Therapeutics Corporation

$23.07B

$543.39Healthcare

Total return — STE vs UTHR

growth of $100 · last 27y

STE +1116.6%UTHR +8817.2%UTHR compounded faster

Log scale — wide-divergence pair

STE UTHR

STE vs UTHR: by the numbers

•UTHR is the larger company ($23.07B vs $20.52B market cap).
•UTHR trades at the lower earnings multiple (20.09 vs 26.56 P/E).
•UTHR converts more revenue to profit (40.61% vs 13.18% net margin).
•UTHR grew revenue faster over the past five years (16.05% vs 13.82% CAGR).
•STE pays a dividend (1.20% yield) while UTHR does not currently pay one.

Which is better, STE or UTHR?

Metric tally: STE 6 · UTHR 10

It depends on what you're optimizing for:

ValueUTHR(lower P/E)

GrowthUTHR(faster 5Y revenue CAGR)

QualityUTHR(higher ROIC)

Metrics side by side

Valuation

Metric	STE	UTHR
P/E ratio	26.56	20.09●
Forward P/E	20.65	16.41●
P/S ratio	3.49●	8.09
P/B ratio	2.88●	4.35
PEG ratio	1.03●	1.16
EV / EBITDA	12.24●	14.34
FCF yield	4.69%●	3.97%

Profitability

Metric	STE	UTHR
Gross margin	44.25%	86.58%●
Operating margin	18.56%	45.34%●
Net margin	13.18%	40.61%●
ROE	10.89%	21.82%●
ROIC	8.47%	16.14%●

Dividends

Metric	STE	UTHR
Dividend yield	1.20%	—
Payout ratio	31.78%	—

Growth (annualized)

Metric	STE	UTHR
Revenue CAGR (5Y)	13.82%	16.05%●
EPS CAGR (5Y)	11.22%	20.93%●
FCF CAGR (5Y)	16.64%●	12.12%
Total return CAGR (5Y)	1.32%	24.73%●

Frequently asked

Which is better, STE or UTHR?: It depends on your goal. value: UTHR (lower P/E); growth: UTHR (faster 5Y revenue CAGR); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 10 to 6.
Is STE or UTHR cheaper?: On trailing earnings, UTHR is cheaper: STE trades at a 26.56 P/E and UTHR at 20.09.
Which has grown faster, STE or UTHR?: Over the past five years, UTHR grew revenue faster — STE at a 13.82% CAGR versus UTHR at 16.05%.
Does STE or UTHR pay a bigger dividend?: STE pays a dividend (1.20% yield) while UTHR does not currently pay one.
Is STE or UTHR more profitable?: UTHR runs the higher net margin — STE at 13.18% versus UTHR at 40.61%.
Which has been the better investment, STE or UTHR?: Over the past 10-year, UTHR delivered the higher annualized total return — STE at 13.60% versus UTHR at 18.19%. Past performance doesn't predict future results.

Go deeper

Full STE analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

STERIS P/E ratio United Therapeutics P/E ratio STERIS dividend yield United Therapeutics dividend yield STERIS ROE United Therapeutics ROE STERIS operating margin United Therapeutics operating margin STERIS revenue growth United Therapeutics revenue growth STERIS free cash flow United Therapeutics free cash flow

STERIS & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.